Jack A. Syage, CEO, Elected Fellow of the American Physical Society (August 2019)

ImmunogenX is featured in the Orange County Business Journal (September 2019)

National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase (August 2019)

ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel (March 2019)

ImmunogenX (50 Best Companies to Watch 2018: May 2018)

Dr. Jennifer Sealey Voyksner and Dr. Jack Syage speak at National Conference (Celiac Disease Foundation: May 5th, 2018)

The Dilemma of the Gluten-Free Diet (Wall Street Journal: April 16th, 2018)

When Going Gluten-Free Is Not Enough: New Tests Detect Hidden Exposure (NPR: April 3rd, 2018)

Gluten-Free Diet May Still Allow Harmful Levels of Exposure (Reuters: March 21st, 2018)